胰淀素受体 (AMYR) 是 G 蛋白偶联受体 (GPCR),对肽激素胰淀素和降钙素有反应。胰淀素最初被发现是 2 型糖尿病患者胰岛淀粉样蛋白沉积的主要成分,在糖尿病猫中,胰淀素也是一种生理相关的循环肽激素。胰淀素受体是异二聚体,由降钙素受体组成,降钙素受体是一种 G 蛋白偶联受体,也是三种受体修饰蛋白之一。功能研究的一个障碍是很难将胰淀素受体表型与降钙素受体表型区分开来。胰淀素受体是治疗肥胖症和代谢紊乱的靶点。
Amylin receptors (AMYRs) are G protein-coupled receptors (GPCRs), which respond to the peptide hormones amylin and calcitonin. Amylin was originally discovered as the main constituent of pancreatic islet amyloid deposits in type 2 diabetics and in diabetic cats, amylin is also a physiologically relevant circulating peptide hormone. Amylin receptors are heterodimers comprising the calcitonin receptor, which is a G protein–coupled receptor, and one of three receptor-modifying proteins. An impediment to functional studies is that it is difficult to separate amylin receptor phenotypes from calcitonin receptor phenotypes. Amylin receptors are targets for treating obesity and metabolic disorders.
(R)-CTR/AMYR activator-1(Compound 122)是一种 CTR/AMYR 激动剂,其 EC50 值分别为 0.8 和 0.73 nM,可用于骨骼疾病、代谢性疾病、心血管疾病以及神经退行性疾病的相关研究。
CTR/AMYR activator-1(化合物122的S构型)是一种CTR/AMYR激活剂,可用于骨骼疾病、代谢疾病、心血管疾病和神经退行性疾病的研究。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号